Bayer EMEA News and Activities

Bayer EMEA is owned by Bayer.

Bayer is one of the...

• Dax 40;
• Forbes Global 2000 (#589);
• Fortune 500 Europe (#69);
• Global Fortune 500 (#301);
• Stoxx 600;
• TOB Iconic 10,000.

Bayer is a company listed under the stock ticker BAYN (DE).

Bayer has a direct presence in 20 countries.

Bayer has 40 subsidiaries including AskBio, Bayer ANZ and Bayer APAC.

They are in:

• Pharmaceuticals68%
• Biotechnology17%
• Other15%

Acquisition, funding and merger involving Bayer.

• Bayer has acquired Perfuse Therapeutics (posted on June 17 2026).
• Bayer has announced the acquisition of Perfuse Therapeutics  (posted on May 6 2026).

View the org chart displaying its 26 main executives

Most searched biographies at Bayer EMEA

• Rebekka Iten, President
• Amalia Chondromatidou, Senior Vice President, Global Head Marketin...
• Christoph Koenen, Head of Clinical Development and Operations

Popular executive movements at Bayer EMEA

• Taygun Gunay who was Senior Vice President and Sub Region Head Eastern Europe, Turkey, Middle East and Africa, becomes Head of Global Strategic Marketing & End-to-End Capability  (posted on February 23 2026).
• Mohamed Galal who was Vice President, Middle East Country, becomes Cluster Head, Middle East & North Africa  (posted on February 23 2026).

Popular executive movements at Bayer

• Alfred Stern has joined the company as Director  (posted on June 9 2026).
• Marcel Smits has joined the company as Director  (posted on June 9 2026).
• Thomas Matthias Meiers has joined the company as Director  (posted on June 9 2026).

Click here to view some more movements at Bayer

Create your alert
to follow the executive moves at Bayer EMEA.

Bayer has 2,422 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ipsen has announced the acquisition of Memo Therapeutics  (posted on July 1 2026).
• Hanmi has acquired Aptose Biosciences (posted on July 1 2026).
• Beeline Medicines has just announced a $126 Million fundraising (posted on June 30 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Bayer EMEA

Social media about Bayer EMEA

• Bayer EMEA on Wikipedia, Google News & Yahoo Finance
• Bayer EMEA on LinkedIn, X (Twitter) & YouTube